1887

Abstract

Introduction:

Diagnosing progressive disseminated histoplasmosis (PDH) in patients with systemic lupus erythematosus (SLE) is diagnostically challenging. Since PDH is lethal when untreated, awareness of this infection in patients with SLE is of utmost importance. To the best of our knowledge, this is the first description of a case of PDH in a patient with SLE in Europe.

Case presentation:

A 56-year-old woman of Surinamese descent with a history of SLE, presented with fever and polyarthritis. Although a flare of SLE was suspected initially, cultures of bone marrow and broncho-alveolar lavage fluid grew .

Conclusion:

This case report highlights that physicians should be aware of progressive disseminated histoplasmosis in patients with SLE treated with immunosuppressive agents. The signs and symptoms can easily mimic a SLE flare, which would then be treated with more aggressive immunosuppression. Failure to recognize the infection will therefore invariably lead to death of the patient. Progressive disseminated histoplasmosis is usually not recognized by doctors in non-endemic areas such as Europe. However, globalisation and more frequent intercontinental traffic of immunocompromised patients currently increases the incidence of histoplasmosis in these areas. It is therefore of life-saving importance that doctors are aware of the features of the infection in areas where is not endemic.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005035
2016-07-11
2021-10-28
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/3/4/jmmcr005035.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005035&mimeType=html&fmt=ahah

References

  1. Colombo A. L., Tobón A., Restrepo A., Queiroz-Telles F., Nucci M. 2011; Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 49:785–798 [View Article][PubMed]
    [Google Scholar]
  2. Connolly P. A., Durkin M. M., Lemonte A. M., Hackett E. J., Wheat L. J. 2007; Detection of Histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 14:1587–1591 [View Article][PubMed]
    [Google Scholar]
  3. Goodwin R. A., Loyd J. E., Des Prez R. M. 1981; Histoplasmosis in normal hosts. Medicine 60:231–266 [View Article][PubMed]
    [Google Scholar]
  4. Hage C. A., Bowyer S., Tarvin S. E., Helper D., Kleiman M. B., Wheat L. J. 2010; Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 50:85–92 [View Article][PubMed]
    [Google Scholar]
  5. Hage C. A., Ribes J. A., Wengenack N. L., Baddour L. M., Assi M., McKinsey D. S., Hammoud K., Alapat D., Babady N. E., other authors. 2011; A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 53:448–454 [View Article][PubMed]
    [Google Scholar]
  6. Lim S. Y., Kijsirichareanchai K., Winn R. 2013; Progressive disseminated histoplasmosis in systemic lupus erythematosus-an unusual presentation of acute tenosynovitis and a literature review. Clin Rheumatol 32:135–139 [View Article][PubMed]
    [Google Scholar]
  7. Naina H. V., Thomas C. F., Jr., Harris S. 2010; Histoplasmosis and asplenia. Thorax 65:372 [View Article][PubMed]
    [Google Scholar]
  8. Porta A., Maresca B. 2000; Host response and Histoplasma capsulatum/macrophage molecular interactions. Med Mycol 38:399–406 [View Article][PubMed]
    [Google Scholar]
  9. Rose F. B., Camp C. J., Chisdak M. 1982; Disseminated histoplasmosis and asplenia. Ann Intern Med 96:790 [View Article][PubMed]
    [Google Scholar]
  10. Stone M. M., Frenkel L. M., Howard D. H. 1990; Histoplasmosis after multiple trauma. Pediatr Infect Dis J 9:747–749[PubMed] [CrossRef]
    [Google Scholar]
  11. Tsokos G. C. 1994; Lymphocytes, cytokines, inflammation, and immune trafficking. Curr Opin Rheumatol 6:461–467 [View Article][PubMed]
    [Google Scholar]
  12. Weng C. T., Lee N. Y., Liu M. F., Weng M. Y., Wu A. B., Chang T. W., Lin T. S., Wang J. Y., Chang H. Y., Wang C. R. 2010; A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan. Lupus 19:1204–1209 [View Article][PubMed]
    [Google Scholar]
  13. Wheat L. J., Slama T. G., Norton J. A., Kohler R. B., Eitzen H. E., French M. L., Sathapatayavongs B. 1982; Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 96:159–163 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005035
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005035
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error